Table 3. Potential biomarkers of SCI severity identified by quantitative LC-MS/MS analysis of CSF from rats following experimental SCI.
Protein ID | Protein Description | Protein Symbol | Moderate/sham | Severe/sham | Gene Ontology | |||
AVG ratios | SEM | AVG ratios | SEM | |||||
1 | IPI00188541 | Inter-alpha-inhibitor H4 heavy chain | Itih4 | 4.5 | 0.41 | 1.8 | 0.33 | hyaluronan metabolic process; acute phase response |
2 | IPI00476458 | Glutathione peroxidase 3 | Gpx3 | 4.2 | 0.30 | 1.9 | 0.27 | glutathione metabolic process; hydrogen peroxide catabolic process; oxidation reduction; protein homotetramerization; response to oxidative stress |
3 | IPI00326140 | Pregnancy zone protein | Pzp | 3.9 | 0.41 | 2.1 | 0.36 | pregnancy |
4 | IPI00360930 | Carbonic anhydrase 1 | Car1 | 2.4 | 0.21 | 0.4 | 0.12 | one-carbon metabolic process |
5 | IPI00207146 | Zero beta-1 globin | MGC72973 | 6.1 | 0.78 | 1.0 | 0.31 | oxygen transport |
6 | IPI00191715 | Alpha-1-acid glycoprotein | Orm1 | 2.1 | 0.18 | 0.9 | 0.21 | acute-phase response; regulation of immune system process |
Proteins consistently changed across three LC-MS/MS runs.
Selection of potential biomarkers of SCI severity was based on more than two-fold difference in the average ratio between the two injury models. AVG – average; SEM – standard error of the mean.